Hyunjeong Ki

Hyunjeong Ki

Auto-generated profile, based on publicly available information

Hyunjeong Ki

Department of Surgery, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2020 in Journal of Minimally Invasive Surgery
Verified
Journal Article
Open access
HKHyun Jeong Ki
Hyun Jeong Ki
JPJun Beom Park
Jun Beom Park
JSJi-Young Sul
Ji-Young Sul
M.M.D.
M.D.
PHPh.D.
Ph.D.
The port site hernia (PSH) is a specific type of incisional hernia related to the trocar sites of laparoscopic surgery. Diastasis recti of the abdominis muscle (DR) is the separation of the rectus muscle by a certain distance. The present study aims to present our experience with umbilical PSH and concomitant DR and to raise awareness of DR as one of the risk factors of umbilical PSH. Eighteen patients with umbilical PSH after laparoscopic abdominal surgery, was retrospectively reviewed. Preoperative CT was analyzed to measure the Inter-recti distance (IRD) for all patients. Other factors, such as trocar size, wound infection, obesity (BMI), port extension, suture materials, and pre-existing co-morbidities, were recorded and analyzed. Extension of the port incision was associated with umbilical PSH. Ten out of eighteen umbilical PSH patients (56%) had DR before they had first laparoscopic surgery. Nine (50%) patients showed sarcopenia. Moreover, four out of five recurrences had DR. More than two recurrences were all associated with DR. Port extension and sarcopenia were risk factors of umbilical PSH. Also, DR might be a possible risk factor of umbilical PSH occurrence and recurrence. Surgeons should be aware of the presence of DR before the planning of the laparoscopic surgery by diagnostic imaging. If DR is associated with umbilical PSH, we need to consider the correction of both pathologies at the same time.

1 January 2025 in Annals of Surgical Treatment and Research
Verified
Journal Article
Open access
PDF file
HKHyunjeong Ki
Hyunjeong Ki
SKSeyoung Koo
Seyoung Koo
GKGil Ho Kang
Gil Ho Kang
JSJiyoung Sul
Jiyoung Sul
JPJun Beom Park
Jun Beom Park
Ki H, et al. Ann Surg Treat Res. 2025 Apr;108(4):211-218. https://doi.org/10.4174/astr.2025.108.4.211

26 June 2026 in The Korean Journal of Pain
Verified
Journal Article
Open access
COChahyun Oh
Chahyun Oh
HKHyunjeong Ki
Hyunjeong Ki
JLJeong Yeon Lee
Jeong Yeon Lee
BHBoohwi Hong
Boohwi Hong
Chaeseong LimChaeseong Lim
Chaeseong Lim
Intraoperative multimodal analgesia with non-opioid agents is standard in perioperative pain management. However, evidence directly comparing triple, dual, and single agent regimens remains limited. This retrospective single-center study analyzed adult patients undergoing minor general surgery, setting in which opioids are not routinely employed for postoperative pain management. The primary outcome was the use of rescue analgesics within 4 hours after surgery, comparing triple (acetaminophen [AAP] + nonsteroidal anti-inflammatory drugs [NSAIDs] + nefopam), dual (AAP + NSAIDs, AAP + nefopam, or NSAIDs + nefopam), and single agent regimens. Comparisons among individual dual agent combinations and among individual single agents were performed as secondary analyses. Outcomes were estimated using multivariable regression with inverse probability of treatment weighting (IPTW). Among 5,601 patients included, 37.9% received single, 58.5% dual, and 3.6% triple agent regimens. Rescue analgesic use occurred in 75.1%, 58.8%, and 43.8% of these groups, respectively. After IPTW adjustment, the triple regimen was associated with significantly lower rescue analgesic use compared with dual regimens (odds ratio, 0.48; 95% confidence interval, 0.32-0.70; P < 0.001), with adjusted probabilities of 31.4% (triple), 49.1% (dual), and 67.2% (single). Among dual regimens, the lowest rescue probability was observed with NSAIDs + nefopam (39.7%), followed by AAP + NSAIDs (53.2%), and AAP + nefopam (58.7%). Triple agent intraoperative non-opioid analgesia was associated with the greatest reduction in postoperative rescue analgesic use, with a stepwise benefit observed across single, dual, and triple regimens. These findings support the active use of multimodal non-opioid analgesia in minor general surgery.